219 related articles for article (PubMed ID: 22844387)
1. Senescence Marker Protein 30: Functional and Structural Insights to its Unknown Physiological Function.
Scott SH; Bahnson BJ
Biomol Concepts; 2011 Dec; 2(6):469-480. PubMed ID: 22844387
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human senescence marker protein 30: insights linking structural, enzymatic, and physiological functions .
Chakraborti S; Bahnson BJ
Biochemistry; 2010 Apr; 49(16):3436-44. PubMed ID: 20329768
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the metal-dependent structural and functional properties of mouse and human SMP30.
Dutta RK; Parween F; Hossain MS; Dhama N; Pandey P; Gupta RD
PLoS One; 2019; 14(6):e0218629. PubMed ID: 31220150
[TBL] [Abstract][Full Text] [Related]
4. Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease.
Kondo Y; Ishigami A
Geriatr Gerontol Int; 2016 Mar; 16 Suppl 1():4-16. PubMed ID: 27018279
[TBL] [Abstract][Full Text] [Related]
5. Lactonases with organophosphatase activity: structural and evolutionary perspectives.
Draganov DI
Chem Biol Interact; 2010 Sep; 187(1-3):370-2. PubMed ID: 20122908
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
Misaka T; Suzuki S; Miyata M; Kobayashi A; Shishido T; Ishigami A; Saitoh S; Hirose M; Kubota I; Takeishi Y
Cardiovasc Res; 2013 Aug; 99(3):461-70. PubMed ID: 23723062
[TBL] [Abstract][Full Text] [Related]
7. Senescence marker protein 30 (SMP30) expression in eukaryotic cells: existence of multiple species and membrane localization.
Arun P; Aleti V; Parikh K; Manne V; Chilukuri N
PLoS One; 2011 Feb; 6(2):e16545. PubMed ID: 21347421
[TBL] [Abstract][Full Text] [Related]
8. Insights into the mechanism of paraoxonase-1: Comparing the reactivity of the six-bladed β-propeller hydrolases.
Grunkemeyer TJ; Mata DG; Doddapaneni K; Murali S; Magliery TJ
Biochemistry; 2018 Dec; ():. PubMed ID: 30547569
[TBL] [Abstract][Full Text] [Related]
9. Release of SMP30 in Extracellular Vesicles under Conditions of Ascorbic Acid Deficiency Is Involved with Acute Phase Response in ODS Rat.
Arakawa K; Inoue H; Ishigami A; Sato A; Takino Y; Tanaka M; Morimoto H; Takahashi N; Uehara M
J Nutr Sci Vitaminol (Tokyo); 2023; 69(6):420-427. PubMed ID: 38171814
[TBL] [Abstract][Full Text] [Related]
10. Senescence marker protein-30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis.
Kondo Y; Masutomi H; Noda Y; Ozawa Y; Takahashi K; Handa S; Maruyama N; Shimizu T; Ishigami A
FEBS Open Bio; 2014; 4():522-32. PubMed ID: 25003023
[TBL] [Abstract][Full Text] [Related]
11. Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver.
Kondo Y; Ishigami A; Kubo S; Handa S; Gomi K; Hirokawa K; Kajiyama N; Chiba T; Shimokado K; Maruyama N
FEBS Lett; 2004 Jul; 570(1-3):57-62. PubMed ID: 15251439
[TBL] [Abstract][Full Text] [Related]
12. Senescence marker protein30 protects lens epithelial cells against oxidative damage by restoring mitochondrial function.
Teng H; Hong Y; Cao J; Li H; Tian F; Sun J; Wen K; Han G; Whelchel A; Zhang X; Li X; Dong L
Bioengineered; 2022 May; 13(5):12955-12971. PubMed ID: 35615975
[TBL] [Abstract][Full Text] [Related]
13. Anti-biofilm potential of human senescence marker protein 30 against Mycobacterium smegmatis.
Yadav P; Goel M; Gupta RD
World J Microbiol Biotechnol; 2023 Dec; 40(2):45. PubMed ID: 38114754
[TBL] [Abstract][Full Text] [Related]
14. Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.
Miyata M; Suzuki S; Misaka T; Shishido T; Saitoh S; Ishigami A; Kubota I; Takeishi Y
PLoS One; 2013; 8(12):e79093. PubMed ID: 24391705
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological significance of senescence marker protein-30.
Maruyama N; Ishigami A; Kondo Y
Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S88-98. PubMed ID: 20590846
[TBL] [Abstract][Full Text] [Related]
16. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
[TBL] [Abstract][Full Text] [Related]
17. Senescence marker protein 30 (SMP30) protects against high glucose-induced apoptosis, oxidative stress and inflammatory response in retinal ganglion cells by enhancing Nrf2 activation via regulation of Akt/GSK-3β pathway.
Zhang L; Zhu T; He F; Li X
Int Immunopharmacol; 2021 Dec; 101(Pt B):108238. PubMed ID: 34688152
[TBL] [Abstract][Full Text] [Related]
18. Ascorbate promotes carbon tetrachloride-induced hepatic injury in senescence marker protein 30-deficient mice by enhancing inflammation.
Ki MR; Lee HR; Park JK; Hong IH; Han SY; You SY; Lee EM; Kim AY; Lee SS; Jeong KS
J Nutr Biochem; 2011 Jun; 22(6):535-42. PubMed ID: 20801630
[TBL] [Abstract][Full Text] [Related]
19. Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice.
Park JK; Ki MR; Lee HR; Hong IH; Ji AR; Ishigami A; Park SI; Kim JM; Chung HY; Yoo SE; Jeong KS
Hepatology; 2010 May; 51(5):1766-77. PubMed ID: 20162732
[TBL] [Abstract][Full Text] [Related]
20. Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes.
Okada H; Senmaru T; Fukui M; Kondo Y; Ishigami A; Maruyama N; Obayashi H; Yamazaki M; Nakamura N; Hasegawa G
J Diabetes Investig; 2015 Jan; 6(1):35-43. PubMed ID: 25621131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
